Here are six key obstacles states are struggling to overcome as they prepare their plans:
- Determining who is eligible to receive the first doses.
- Assuring masses of increasingly apprehensive citizens that the shots are safe.
- Transporting vaccines from drugmakers to healthcare facilities.
- Combining the federal government’s top-down guidance with a mostly bottom-up delivery system.
- Storing Pfizer and BioNTech’s vaccine, which must be kept at -94 degrees.
- Tracking who received the vaccine, as well as when and where, as most of the vaccine candidates require two doses weeks apart.
More articles on pharmacy:
J&J pauses COVID-19 vaccine trial over participant’s ‘unexplained illness’
HHS fund protects drugmakers from coronavirus vaccine-related liabilities
Eli Lilly halts COVID-19 antibody drug trial over safety concern
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
